First Fiduciary Investment Counsel, Inc. Novartis Ag Transaction History

First Fiduciary Investment Counsel, Inc.

$499 Million
Q3 2024

A detailed history of First Fiduciary Investment Counsel, Inc. transactions in Novartis Ag stock. As of the latest transaction made, First Fiduciary Investment Counsel, Inc. holds 140,451 shares of NVS stock, worth $13.8 Million. This represents 3.23% of its overall portfolio holdings.

Number of Shares

140,451

Previous 141,572 0.79%

Holding current value

$13.8 Million

Previous $15.1 Million 7.19%

% of portfolio

3.23%

Previous 3.27%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$106.13 - $120.89 $118,971 - $135,517	-1,121 Reduced 0.79%	140,451 $16.2 Million
Q2 2024 Aug 07, 2024	BUY	$92.57 - $107.37 $47,025 - $54,543	508 Added 0.36%	141,572 $15.1 Million
Q1 2024 Apr 24, 2024	SELL	$95.27 - $108.47 $280,093 - $318,901	-2,940 Reduced 2.04%	141,064 $13.6 Million
Q4 2023 Feb 02, 2024	SELL	$92.27 - $101.54 $159,350 - $175,359	-1,727 Reduced 1.19%	144,004 $14.5 Million
Q3 2023 Nov 07, 2023	SELL	$94.73 - $105.13 $486,912 - $540,368	-5,140 Reduced 3.41%	145,731 $14.8 Million
Q2 2023 Jul 21, 2023	SELL	$92.52 - $104.91 $316,603 - $359,002	-3,422 Reduced 2.22%	150,871 $15.2 Million
Q1 2023 May 04, 2023	SELL	$80.03 - $92.81 $328,443 - $380,892	-4,104 Reduced 2.59%	154,293 $14.2 Million
Q4 2022 Feb 07, 2023	SELL	$75.55 - $92.52 $179,960 - $220,382	-2,382 Reduced 1.48%	158,397 $14.4 Million
Q3 2022 Oct 31, 2022	SELL	$74.61 - $87.26 $66,104 - $77,312	-886 Reduced 0.55%	160,779 $12.2 Million
Q2 2022 Jul 19, 2022	SELL	$80.52 - $93.75 $620,487 - $722,437	-7,706 Reduced 4.55%	161,665 $13.7 Million
Q1 2022 Apr 21, 2022	SELL	$80.11 - $90.62 $68,253 - $77,208	-852 Reduced 0.5%	169,371 $14.9 Million
Q4 2021 Jan 14, 2022	BUY	$79.7 - $88.13 $226,746 - $250,729	2,845 Added 1.7%	170,223 $14.9 Million
Q3 2021 Oct 07, 2021	SELL	$81.78 - $95.14 $159,471 - $185,523	-1,950 Reduced 1.15%	167,378 $13.7 Million
Q2 2021 Jul 29, 2021	SELL	$85.24 - $94.15 $366,787 - $405,127	-4,303 Reduced 2.48%	169,328 $15.4 Million
Q1 2021 May 12, 2021	SELL	$83.5 - $98.47 $1.93 Million - $2.27 Million	-23,062 Reduced 11.72%	173,631 $14.8 Million
Q4 2020 Feb 12, 2021	BUY	$78.07 - $94.43 $286,673 - $346,746	3,672 Added 1.9%	196,693 $18.6 Million
Q3 2020 Nov 18, 2020	BUY	$82.14 - $91.0 $499,493 - $553,371	6,081 Added 3.25%	193,021 $16.8 Million
Q2 2020 Aug 10, 2020	SELL	$80.93 - $91.1 $56,084 - $63,132	-693 Reduced 0.37%	186,940 $16.3 Million
Q1 2020 May 12, 2020	SELL	$70.67 - $99.01 $63,673 - $89,208	-901 Reduced 0.48%	187,633 $15.5 Million
Q4 2019 Feb 12, 2020	BUY	$84.35 - $95.37 $489,651 - $553,622	5,805 Added 3.18%	188,534 $17.9 Million
Q3 2019 Nov 15, 2019	SELL	$85.54 - $94.26 $635,989 - $700,823	-7,435 Reduced 3.91%	182,729 $15.9 Million
Q2 2019 Jul 25, 2019	SELL	$75.4 - $92.8 $2.56 Million - $3.15 Million	-33,997 Reduced 15.17%	190,164 $17.4 Million
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $626,662 - $716,768	-8,320 Reduced 3.58%	224,161 $21.6 Million
Q4 2018 Feb 04, 2019	BUY	$73.66 - $82.02 $202,196 - $225,144	2,745 Added 1.19%	232,481 $19.9 Million
Q3 2018 Oct 29, 2018	BUY	$66.94 - $77.43 $158,313 - $183,121	2,365 Added 1.04%	229,736 $19.8 Million
Q2 2018 Aug 15, 2018	BUY	$64.91 - $73.36 $47,708 - $53,919	735 Added 0.32%	227,371 $17.2 Million
Q1 2018 May 03, 2018	SELL	$70.39 - $84.15 $97,982 - $117,136	-1,392 Reduced 0.61%	226,636 $18.3 Million
Q4 2017 Feb 20, 2018	SELL	$72.33 - $77.64 $347,545 - $373,060	-4,805 Reduced 2.06%	228,028 $19.1 Million
Q3 2017 Nov 20, 2017	SELL	$74.14 - $77.27 $931,939 - $971,283	-12,570 Reduced 5.12%	232,833 $20 Million
Q2 2017 Aug 15, 2017	BUY	N/A	245,403	245,403 $20.5 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Fiduciary Investment Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Fiduciary Investment Counsel, Inc. with notifications on news.

Account

First Fiduciary Investment Counsel, Inc. Novartis Ag Transaction History